These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10087328)

  • 41. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases.
    Specht JM; Wang G; Do MT; Lam JS; Royal RE; Reeves ME; Rosenberg SA; Hwu P
    J Exp Med; 1997 Oct; 186(8):1213-21. PubMed ID: 9334360
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein.
    Zabaleta A; Llopiz D; Arribillaga L; Silva L; Riezu-Boj JI; Lasarte JJ; Borrás-Cuesta F; Prieto J; Sarobe P
    Mol Ther; 2008 Jan; 16(1):210-7. PubMed ID: 17923840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide.
    Oh ST; Kim CH; Park MY; Won EH; Sohn HJ; Cho HI; Kang WK; Hong YK; Kim TG
    Vaccine; 2006 Apr; 24(15):2860-8. PubMed ID: 16443309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses.
    Worgall S; Busch A; Rivara M; Bonnyay D; Leopold PL; Merritt R; Hackett NR; Rovelink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
    J Virol; 2004 Mar; 78(5):2572-80. PubMed ID: 14963160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors.
    Hensley SE; Giles-Davis W; McCoy KC; Weninger W; Ertl HC
    J Immunol; 2005 Nov; 175(9):6032-41. PubMed ID: 16237098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor.
    Lee CT; Wu S; Ciernik IF; Chen H; Nadaf-Rahrov S; Gabrilovich D; Carbone DP
    Hum Gene Ther; 1997 Jan; 8(2):187-93. PubMed ID: 9017422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo and in vitro modulation of immune stimulatory capacity of primary dendritic cells by adenovirus-mediated gene transduction.
    Sonderbye L; Feng S; Yacoubian S; Buehler H; Ahsan N; Mulligan R; Langhoff E
    Exp Clin Immunogenet; 1998; 15(2):100-11. PubMed ID: 9691204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Production of specific antibody and T helper 1-dominant cytokine elicited by dendritic cells genetically modified with an adenovirus vector.
    Inoue N; Kanaoka S; Yamasaki S; Arii S; Imamura M
    Immunol Lett; 1999 Nov; 70(2):77-81. PubMed ID: 10569695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials.
    Mossoba ME; Medin JA
    Expert Rev Vaccines; 2006 Oct; 5(5):717-32. PubMed ID: 17181444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growth.
    Bryson PD; Han X; Truong N; Wang P
    Vaccine; 2017 Oct; 35(43):5842-5849. PubMed ID: 28916248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53.
    Nikitina EY; Chada S; Muro-Cacho C; Fang B; Zhang R; Roth JA; Gabrilovich DI
    Gene Ther; 2002 Mar; 9(5):345-52. PubMed ID: 11938454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene.
    Reeves ME; Royal RE; Lam JS; Rosenberg SA; Hwu P
    Cancer Res; 1996 Dec; 56(24):5672-7. PubMed ID: 8971174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transduction with a fiber-modified adenoviral vector is superior to non-viral nucleofection for expressing tumor-associated Ag mucin-1 in human DC.
    van Leeuwen EB; Cloosen S; Senden-Gijsbers BL; Germeraad WT; Bos GM
    Cytotherapy; 2006; 8(1):36-46. PubMed ID: 16627343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of anti-tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice.
    Chen L; Tang XD; Yu ST; Ai ZH; Fang DC; Cai YG; Luo YH; Liang GP; Yang SM
    J Pathol; 2009 Apr; 217(5):685-92. PubMed ID: 19142972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor protection following vaccination with low doses of lentivirally transduced DCs expressing the self-antigen erbB2.
    Mossoba ME; Walia JS; Rasaiah VI; Buxhoeveden N; Head R; Ying C; Foley JE; Bramson JL; Fowler DH; Medin JA
    Mol Ther; 2008 Mar; 16(3):607-17. PubMed ID: 18180774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication.
    Miller PW; Sharma S; Stolina M; Butterfield LH; Luo J; Lin Y; Dohadwala M; Batra RK; Wu L; Economou JS; Dubinett SM
    Hum Gene Ther; 2000 Jan; 11(1):53-65. PubMed ID: 10646639
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells.
    Gong J; Chen L; Chen D; Kashiwaba M; Manome Y; Tanaka T; Kufe D
    Gene Ther; 1997 Oct; 4(10):1023-8. PubMed ID: 9415307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.
    Murakami T; Tokunaga N; Waku T; Gomi S; Kagawa S; Tanaka N; Fujiwara T
    Clin Cancer Res; 2004 Jun; 10(11):3871-80. PubMed ID: 15173096
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors involved in the maturation of murine dendritic cells transduced with adenoviral vector variants.
    Kanagawa N; Koretomo R; Murakami S; Sakurai F; Mizuguchi H; Nakagawa S; Fujita T; Yamamoto A; Okada N
    Virology; 2008 May; 374(2):411-20. PubMed ID: 18272197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.